Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Kai Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109701221. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer. Co-author DOI 10.1038/s41467-026-73871-x↗
  2. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. Co-author DOI 10.1186/s13046-023-02792-0↗
  3. Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma. Co-author DOI 10.7717/peerj.12736↗
  4. Development and validation of a ferroptosis-related prognostic model in pancreatic cancer. Co-author DOI 10.1007/s10637-021-01114-5↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wentao Gao · 3 shared papers, 2021–2023 · strength 0.48
  2. Chaozhi Yang · 2 shared papers, 2021–2022 · strength 0.29
  3. Chenjie Qiu · 2 shared papers, 2021–2022 · strength 0.29
  4. Min Tu · 2 shared papers, 2021–2022 · strength 0.29
  5. Feng Chen · 1 shared paper, 2026 · strength 0.25
  6. Wei Cui · 1 shared paper, 2026 · strength 0.25
  7. Hezhi Fang · 1 shared paper, 2026 · strength 0.25
  8. Ruijun Tian · 1 shared paper, 2026 · strength 0.25
  9. Yabin Yu · 1 shared paper, 2023 · strength 0.18
  10. Kai Zhang · 1 shared paper, 2022 · strength 0.16
  11. Kuirong Jiang · 1 shared paper, 2022 · strength 0.16
  12. Kai Zhang · 1 shared paper, 2021 · strength 0.13
  13. Kuirong Jiang · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.